Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh Gallagher

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Primary Care & Community Health|January 6, 2023
Step-Wise Management of Anemia in Patients With Chronic Kidney Disease in Primary Care: Qualitative StudyGayathri Delanerolle, Anna Forbes, Jeremy van Vlymen, et al.
Heart (British Cardiac Society)|March 11, 2026
Model-based cost-effectiveness analysis of first-line pharmacotherapy combinations in adults with chronic heart failure and reduced ejection fractionAlfredo Mariani, Kirsty Luckham, Lisa Miles, et al.
BMC Nephrology|April 13, 2017
A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapyHugh Gallagher, Shona Methven, Anna Casula, et al.
Trials|April 22, 2022
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney diseaseHugh Gallagher, Jennifer Dumbleton, Tom Maishman, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|December 11, 2023
Investigating the effectiveness of oral ketamine on pain, mood and quality of life in treatment resistant chronic painSammy Al Mukhaizeem, Anurag Nasa, Dympna Waldron, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Primary Care & Community Health|January 6, 2023
Step-Wise Management of Anemia in Patients With Chronic Kidney Disease in Primary Care: Qualitative StudyGayathri Delanerolle, Anna Forbes, Jeremy van Vlymen, et al.
Heart (British Cardiac Society)|March 11, 2026
Model-based cost-effectiveness analysis of first-line pharmacotherapy combinations in adults with chronic heart failure and reduced ejection fractionAlfredo Mariani, Kirsty Luckham, Lisa Miles, et al.
BMC Nephrology|April 13, 2017
A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapyHugh Gallagher, Shona Methven, Anna Casula, et al.
Trials|April 22, 2022
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney diseaseHugh Gallagher, Jennifer Dumbleton, Tom Maishman, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|December 11, 2023
Investigating the effectiveness of oral ketamine on pain, mood and quality of life in treatment resistant chronic painSammy Al Mukhaizeem, Anurag Nasa, Dympna Waldron, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Pageof 5